Recent  ||| S:0 E:7 ||| JJ
developments  ||| S:7 E:20 ||| NNS
in  ||| S:20 E:23 ||| IN
nanostructure  ||| S:23 E:37 ||| FW
based  ||| S:37 E:43 ||| FW
electrochemical  ||| S:43 E:59 ||| FW
glucose  ||| S:59 E:67 ||| FW
sensors  ||| S:67 E:75 ||| FW
Diabetes  ||| S:75 E:84 ||| NNP
is  ||| S:84 E:87 ||| VBZ
a  ||| S:87 E:89 ||| DT
major  ||| S:89 E:95 ||| JJ
health  ||| S:95 E:102 ||| NN
problem  ||| S:102 E:110 ||| NN
causing  ||| S:110 E:118 ||| VBG
4  ||| S:118 E:120 ||| CD
million  ||| S:120 E:128 ||| CD
deaths  ||| S:128 E:135 ||| NNS
each  ||| S:135 E:140 ||| DT
year  ||| S:140 E:145 ||| NN
and  ||| S:145 E:149 ||| CC
171  ||| S:149 E:153 ||| CD
million  ||| S:153 E:161 ||| CD
people  ||| S:161 E:168 ||| NNS
suffering  ||| S:168 E:178 ||| VBG
worldwide ||| S:178 E:187 ||| NNS
.  ||| S:187 E:189 ||| .
Although  ||| S:189 E:198 ||| IN
there  ||| S:198 E:204 ||| EX
is  ||| S:204 E:207 ||| VBZ
no  ||| S:207 E:210 ||| DT
cure  ||| S:210 E:215 ||| NN
for  ||| S:215 E:219 ||| IN
diabetes ||| S:219 E:227 ||| NN
,  ||| S:227 E:229 ||| ,
nevertheless ||| S:229 E:241 ||| RB
,  ||| S:241 E:243 ||| ,
the  ||| S:243 E:247 ||| DT
blood  ||| S:247 E:253 ||| NN
glucose  ||| S:253 E:261 ||| NN
level  ||| S:261 E:267 ||| NN
of  ||| S:267 E:270 ||| IN
diabetic  ||| S:270 E:279 ||| JJ
patients  ||| S:279 E:288 ||| NNS
should  ||| S:288 E:295 ||| MD
be  ||| S:295 E:298 ||| VB
monitored  ||| S:298 E:308 ||| VBN
tightly  ||| S:308 E:316 ||| RB
to  ||| S:316 E:319 ||| TO
avoid  ||| S:319 E:325 ||| VB
further  ||| S:325 E:333 ||| JJ
complications ||| S:333 E:346 ||| NNS
.  ||| S:346 E:348 ||| .
Thus ||| S:348 E:352 ||| RB
,  ||| S:352 E:354 ||| ,
monitoring  ||| S:354 E:365 ||| VBG
of  ||| S:365 E:368 ||| IN
glucose  ||| S:368 E:376 ||| NN
in  ||| S:376 E:379 ||| IN
blood  ||| S:379 E:385 ||| NN
has  ||| S:385 E:389 ||| VBZ
become  ||| S:389 E:396 ||| VBN
an  ||| S:396 E:399 ||| DT
inevitable  ||| S:399 E:410 ||| JJ
need  ||| S:410 E:415 ||| NN
leading  ||| S:415 E:423 ||| VBG
to  ||| S:423 E:426 ||| TO
fabrication  ||| S:426 E:438 ||| VB
of  ||| S:438 E:441 ||| IN
accurate  ||| S:441 E:450 ||| JJ
and  ||| S:450 E:454 ||| CC
sensitive  ||| S:454 E:464 ||| JJ
advanced  ||| S:464 E:473 ||| JJ
blood  ||| S:473 E:479 ||| NN
sugar  ||| S:479 E:485 ||| NN
detection  ||| S:485 E:495 ||| NN
devices  ||| S:495 E:503 ||| NNS
for  ||| S:503 E:507 ||| IN
clinical  ||| S:507 E:516 ||| JJ
diagnosis  ||| S:516 E:526 ||| NN
and  ||| S:526 E:530 ||| CC
personal  ||| S:530 E:539 ||| JJ
care ||| S:539 E:543 ||| NN
.  ||| S:543 E:545 ||| .
It  ||| S:545 E:548 ||| PRP
led  ||| S:548 E:552 ||| VBD
to  ||| S:552 E:555 ||| TO
the  ||| S:555 E:559 ||| DT
development  ||| S:559 E:571 ||| NN
of  ||| S:571 E:574 ||| IN
enzymatic  ||| S:574 E:584 ||| JJ
glucose  ||| S:584 E:592 ||| JJ
sensing  ||| S:592 E:600 ||| JJ
approach ||| S:600 E:608 ||| NN
.  ||| S:608 E:610 ||| .
Later  ||| S:610 E:616 ||| RB
on ||| S:616 E:618 ||| IN
,  ||| S:618 E:620 ||| ,
various  ||| S:620 E:628 ||| JJ
types  ||| S:628 E:634 ||| NNS
of  ||| S:634 E:637 ||| IN
nanostructures  ||| S:637 E:652 ||| NNS
have  ||| S:652 E:657 ||| VBP
been  ||| S:657 E:662 ||| VBN
utilized  ||| S:662 E:671 ||| JJ
owing  ||| S:671 E:677 ||| NN
to  ||| S:677 E:680 ||| TO
their  ||| S:680 E:686 ||| PRP$
high  ||| S:686 E:691 ||| JJ
surface  ||| S:691 E:699 ||| NN
area ||| S:699 E:703 ||| NN
,  ||| S:703 E:705 ||| ,
great  ||| S:705 E:711 ||| JJ
stability ||| S:711 E:720 ||| NN
,  ||| S:720 E:722 ||| ,
and  ||| S:722 E:726 ||| CC
cost  ||| S:726 E:731 ||| NN
effectiveness  ||| S:731 E:745 ||| NN
for  ||| S:745 E:749 ||| IN
the  ||| S:749 E:753 ||| DT
fabrication  ||| S:753 E:765 ||| NN
of  ||| S:765 E:768 ||| IN
enzymatic  ||| S:768 E:778 ||| NN
as  ||| S:778 E:781 ||| IN
well  ||| S:781 E:786 ||| RB
as  ||| S:786 E:789 ||| RB
for  ||| S:789 E:793 ||| IN
nonenzymatic  ||| S:793 E:806 ||| JJ
glucose  ||| S:806 E:814 ||| JJ
sensing  ||| S:814 E:822 ||| JJ
approach ||| S:822 E:830 ||| NN
.  ||| S:830 E:832 ||| .
This  ||| S:832 E:837 ||| DT
work  ||| S:837 E:842 ||| NN
reviews  ||| S:842 E:850 ||| NNS
on  ||| S:850 E:853 ||| IN
both  ||| S:853 E:858 ||| DT
categories ||| S:858 E:868 ||| NNS
,  ||| S:868 E:870 ||| ,
however  ||| S:870 E:878 ||| RB
it  ||| S:878 E:881 ||| PRP
is  ||| S:881 E:884 ||| VBZ
not  ||| S:884 E:888 ||| RB
intended  ||| S:888 E:897 ||| VBN
to  ||| S:897 E:900 ||| TO
discuss  ||| S:900 E:908 ||| VB
all  ||| S:908 E:912 ||| PDT
the  ||| S:912 E:916 ||| DT
research  ||| S:916 E:925 ||| NN
reports  ||| S:925 E:933 ||| VBZ
published  ||| S:933 E:943 ||| VBN
regarding  ||| S:943 E:953 ||| VBG
nanostructure  ||| S:953 E:967 ||| NNS
based  ||| S:967 E:973 ||| VBN
enzymatic  ||| S:973 E:983 ||| NNS
and  ||| S:983 E:987 ||| CC
nonenzymatic  ||| S:987 E:1000 ||| JJ
approaches  ||| S:1000 E:1011 ||| NNS
between  ||| S:1011 E:1019 ||| IN
mid-2010  ||| S:1019 E:1028 ||| NNP
and  ||| S:1028 E:1032 ||| CC
mid-2015 ||| S:1032 E:1040 ||| NNP
.  ||| S:1040 E:1042 ||| .
We ||| S:1042 E:1044 ||| PRP
,  ||| S:1044 E:1046 ||| ,
do ||| S:1046 E:1048 ||| VBP
,  ||| S:1048 E:1050 ||| ,
however ||| S:1050 E:1057 ||| RB
,  ||| S:1057 E:1059 ||| ,
focused  ||| S:1059 E:1067 ||| VBN
to  ||| S:1067 E:1070 ||| TO
describe  ||| S:1070 E:1079 ||| VB
the  ||| S:1079 E:1083 ||| DT
details  ||| S:1083 E:1091 ||| NNS
of  ||| S:1091 E:1094 ||| IN
many  ||| S:1094 E:1099 ||| JJ
substantial  ||| S:1099 E:1111 ||| JJ
articles  ||| S:1111 E:1120 ||| NNS
explaining  ||| S:1120 E:1131 ||| VBG
the  ||| S:1131 E:1135 ||| DT
design  ||| S:1135 E:1142 ||| NN
of  ||| S:1142 E:1145 ||| IN
sensors ||| S:1145 E:1152 ||| NNS
,  ||| S:1152 E:1154 ||| ,
and  ||| S:1154 E:1158 ||| CC
utilities  ||| S:1158 E:1168 ||| NNS
of  ||| S:1168 E:1171 ||| IN
the  ||| S:1171 E:1175 ||| DT
prepared  ||| S:1175 E:1184 ||| JJ
sensors ||| S:1184 E:1191 ||| NNS
,  ||| S:1191 E:1193 ||| ,
so  ||| S:1193 E:1196 ||| RB
that  ||| S:1196 E:1201 ||| IN
readers  ||| S:1201 E:1209 ||| NNS
might  ||| S:1209 E:1215 ||| MD
get  ||| S:1215 E:1219 ||| VB
the  ||| S:1219 E:1223 ||| DT
principles  ||| S:1223 E:1234 ||| NNS
behind  ||| S:1234 E:1241 ||| IN
such  ||| S:1241 E:1246 ||| JJ
devices  ||| S:1246 E:1254 ||| NNS
and  ||| S:1254 E:1258 ||| CC
relevant  ||| S:1258 E:1267 ||| JJ
detection  ||| S:1267 E:1277 ||| JJ
strategies ||| S:1277 E:1287 ||| NNS
.  ||| S:1287 E:1289 ||| .
This  ||| S:1289 E:1294 ||| DT
work  ||| S:1294 E:1299 ||| NN
also  ||| S:1299 E:1304 ||| RB
focuses  ||| S:1304 E:1312 ||| VBZ
on  ||| S:1312 E:1315 ||| IN
biocompatibility  ||| S:1315 E:1332 ||| NN
and  ||| S:1332 E:1336 ||| CC
toxicity  ||| S:1336 E:1345 ||| NN
of  ||| S:1345 E:1348 ||| IN
nanomaterials  ||| S:1348 E:1362 ||| NN
as  ||| S:1362 E:1365 ||| IN
well  ||| S:1365 E:1370 ||| RB
as  ||| S:1370 E:1373 ||| RB
provides  ||| S:1373 E:1382 ||| VBZ
a  ||| S:1382 E:1384 ||| DT
critical  ||| S:1384 E:1393 ||| JJ
opinion  ||| S:1393 E:1401 ||| NN
and  ||| S:1401 E:1405 ||| CC
discussions  ||| S:1405 E:1417 ||| NNS
about  ||| S:1417 E:1423 ||| IN
misconceptions  ||| S:1423 E:1438 ||| NN
in  ||| S:1438 E:1441 ||| IN
glucose  ||| S:1441 E:1449 ||| JJ
sensors ||| S:1449 E:1456 ||| NNS
.  ||| S:1456 E:1458 ||| .
